DIAGNOS Statistics
Total Valuation
DIAGNOS has a market cap or net worth of 19.09 million. The enterprise value is 19.43 million.
| Market Cap | 19.09M |
| Enterprise Value | 19.43M |
Important Dates
The next estimated earnings date is Friday, June 6, 2025.
| Earnings Date | Jun 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +14.91% |
| Shares Change (QoQ) | +13.81% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 96.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 215.64 |
| PB Ratio | -57.57 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -7.44 |
| EV / Sales | 211.53 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -9.54 |
Financial Position
The company has a current ratio of 0.95
| Current Ratio | 0.95 |
| Quick Ratio | 0.91 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.12 |
| Interest Coverage | -5.45 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -99.03% |
| Return on Invested Capital (ROIC) | -127.84% |
| Return on Capital Employed (ROCE) | -17,034.75% |
| Revenue Per Employee | 4,025 |
| Profits Per Employee | -118,720 |
| Employee Count | 22 |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.08% in the last 52 weeks. The beta is -0.59, so DIAGNOS's price volatility has been lower than the market average.
| Beta (5Y) | -0.59 |
| 52-Week Price Change | -13.08% |
| 50-Day Moving Average | 0.21 |
| 200-Day Moving Average | 0.23 |
| Relative Strength Index (RSI) | 41.86 |
| Average Volume (20 Days) | 52,114 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, DIAGNOS had revenue of 88,546 and -2.61 million in losses. Loss per share was -0.03.
| Revenue | 88,546 |
| Gross Profit | -605,629 |
| Operating Income | -2.22M |
| Pretax Income | -2.61M |
| Net Income | -2.61M |
| EBITDA | -2.20M |
| EBIT | -2.22M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 1.96 million in cash and 2.28 million in debt, giving a net cash position of -323,689.
| Cash & Cash Equivalents | 1.96M |
| Total Debt | 2.28M |
| Net Cash | -323,689 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -331,660 |
| Book Value Per Share | -0.00 |
| Working Capital | -106,012 |
Cash Flow
In the last 12 months, operating cash flow was -2.03 million and capital expenditures -9,180, giving a free cash flow of -2.04 million.
| Operating Cash Flow | -2.03M |
| Capital Expenditures | -9,180 |
| Free Cash Flow | -2.04M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -2,509.06% |
| Pretax Margin | -2,949.69% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
DIAGNOS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.91% |
| Shareholder Yield | -14.91% |
| Earnings Yield | -13.68% |
| FCF Yield | -10.66% |
Stock Splits
The last stock split was on April 24, 2019. It was a reverse split with a ratio of 0.1.
| Last Split Date | Apr 24, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
DIAGNOS has an Altman Z-Score of -22.52. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -22.52 |
| Piotroski F-Score | n/a |